Srabani Mittal (15 August 1965–10 August 2019)14/08/2019
The Screening Group (SCR) team is saddened by the passing of long-time SCR collaborator Doctor Srabani Mittal from Kolkata, India, who died on Saturday 10 August 2019 in Dhaka, Bangladesh.
Read the IARC news.
Registration of new trainers and trainees for the IFCPC-IARC Training course in Colposcopy and the prevention of Cervical Cancer14/08/2019
Registration of new trainers and trainees for the IFCPC-IARC Training course in Colposcopy and the prevention of Cervical Cancer will be open at the IFCPC-IARC stall at the 33rd Annual Conference of AICC RCOG 2019.
Exciting new opportunities for the trainers and trainees.
For further details about this training and registration.
Workshop on Early detection of cervical and breast cancer in Kolkata, India – 08/09/201914/08/2019
As part of the 33rd Annual Conference of AICC RCOG 2019, a post-congress workshop will be organized by IARC and IFCPC. Faculty include Dr. R. Sankaranarayanan, Dr Partha Basu, Dr. Neerja Bhatla and Dr. Theresa Freeman Wong.
More details available here for the registration.
New publication: Cancer Screening in Five Continents (CanScreen5) – a project designed to improve the quality of cancer screening programmes08/08/2019
This new article, published in the 6th edition of the annual Cancer Control 2019, presented the new IARC initiative, CanScreen5 platform to uniformly collect, analyse, store and disseminate information on characteristics and performance of cancer screening pogrammes. This new initiative will impress upon the programme managers the value of monitoring and quality improvement of cancer screening programmes and also support capacity-building in this area.View the article and visit the CanScreen5 platform.
New publication: Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women05/08/2019
The Screening Group is delighted to present the findings of this study which aimed to determine the clinical performance of HPV mRNA compared with HPV DNA testing in North Eastern Thailand in the setting of the cervical cancer screening national program. The test characteristics of HPV DNA test and HPV mRNA test for primary screening were comparable. View the article.
IAEA-imPACT mission in Seychelles22/07/2019 – 26/07/2019
Dr Catherine Sauvaget participated to a cancer control assessment mission organised by IAEA, WHO and IARC in the Seychelles.
WHO-EMRO Assessment visit in Palestine20/07/2019 – 26/07/2019
Dr Partha Basu attended the Mission organized by the WHO (EMRO) in collaboration with the Ministry of Health, Palestine to improve cancer care including breast cancer early detection in Palestine.
Postdoctoral Fellowships: Mrs Charlotte Bauquier, PhD in social psychology15/07/2019 – 31/12/2019
Charlotte Bauquier, PhD in social psychology, has recently joined the screening group at IARC as a postdoctoral fellow. She will work with Dr Patricia Villain until the end of December at first instance. Charlotte will be involved in implementing an online education intervention regarding HPV vaccination and targeting French general practitioners (PAPRICA project) . She will also conduct a literature review on shared decision aids and evaluation instruments in breast cancer screening used in France in the last 5 years (CANelles project).
Visit of Dr Suleeporn Sangrajrang, National Cancer Institute, Bangkok, Thailand08/07/2019 – 10/07/2019
Dr Suleeporn Sangrajrang, Deputy Director, Health System Development from the National Cancer Institute in Thailand visited the Screening group to work on the Cancer Screening in 5 continents (CanScreen5) project and to discuss areas of potential collaborations.
WHO New essential medicines and diagnostics lists published today09/07/2019
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. Published today, the two lists focus on cancer and other global health challenges, with an emphasis on effective solutions, smart prioritization, and optimal access for patients. WHO added 12 tests to the WHO Essential Diagnostics List to detect a wide range of solid tumours such as colorectal, liver, lymphoma, cervical, prostate, breast and germ cell cancers, as well as leukemia and lymphoma. Visit the WHO updates global guidance on medicines and diagnostic tests to address health challenges, prioritize highly effective therapeutics, and improve affordable access.